New antibody suppresses HIV for 28 days after single dose

A new lab-made antibody can suppress HIV for up to 28 days after only a single dose, researchers at the Rockefeller University in New York have found.

Their work was published in the journal Nature on 8 April and was the first time that a new generation of HIV antibodies had been tested in humans.

‘We conclude that, as a single agent, 3BNC117 is safe and effective in reducing HIV-1 viraemia, and that immunotherapy should be explored as a new modality for HIV-1 prevention, therapy and cure,’ wrote the study’s lead author, Michel Nussenzweig.

Full article

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *